Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
Cost of Revenue | 6.00K | 6.00K | 6.00K | 5.90K | 5.90K |
Gross Profit | 66.40K | 66.40K | 66.40K | 66.40K | 66.40K |
SG&A Expenses | 2.33M | 2.41M | 2.47M | 2.56M | 2.66M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.24M | 4.99M | 4.78M | 4.13M | 3.89M |
Operating Income | -5.17M | -4.92M | -4.71M | -4.06M | -3.82M |
Income Before Tax | -4.90M | -4.62M | -4.39M | -3.71M | -3.45M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -4.90 | -4.62 | -4.39 | -3.71 | -3.45 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -4.90M | -4.62M | -4.39M | -3.78M | -3.51M |
EBIT | -5.17M | -4.92M | -4.71M | -4.06M | -3.82M |
EBITDA | -5.16M | -3.91M | -2.82M | -1.01M | -- |
EPS Basic | -1.02 | -1.14 | -1.19 | -1.18 | -1.18 |
Normalized Basic EPS | -0.64 | -0.71 | -0.74 | -0.72 | -0.72 |
EPS Diluted | -1.02 | -1.14 | -1.19 | -1.18 | -1.18 |
Normalized Diluted EPS | -0.64 | -0.71 | -0.74 | -0.72 | -0.72 |
Average Basic Shares Outstanding | 19.56M | 16.33M | 14.71M | 13.30M | 12.11M |
Average Diluted Shares Outstanding | 19.56M | 16.33M | 14.71M | 13.30M | 12.11M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |